| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 06/28/2001 | DE19962300A1 New N-benzylindolyl glyoxylic acid derivatives are useful as antitumor agents |
| 06/28/2001 | CA2395113A1 Pyrazole cyclic amp-specific pde inhibitors |
| 06/28/2001 | CA2394864A1 Novel compounds |
| 06/28/2001 | CA2394852A1 Substituted pyrroles |
| 06/28/2001 | CA2394604A1 Substituted acylhydroxamic acids and method of reducing tnf.alpha. levels |
| 06/28/2001 | CA2394095A1 Novel piperidine and piperazine derivatives |
| 06/28/2001 | CA2393837A1 Use of desloratadine for treating allergic and inflammatory conditions in pediatric patients |
| 06/28/2001 | CA2389479A1 Butyne diol derivatives |
| 06/28/2001 | CA2388669A1 Inhibitors of farnesyl protein transferase |
| 06/28/2001 | CA2387579A1 Farnesyl transferase inhibitors |
| 06/27/2001 | EP1110954A1 Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 06/27/2001 | EP1110953A1 Quinazoline derivatives |
| 06/27/2001 | EP1110453A1 Triazolyloxybenzyl alkoxyacrylic acid esters, process for producing them and their use |
| 06/27/2001 | EP1109965A1 Method of treating a textile |
| 06/27/2001 | EP1109884A1 Composition and method for bleaching a substrate |
| 06/27/2001 | EP1109815A1 Chemokine receptor antagonists and methods of use therefor |
| 06/27/2001 | EP1109805A1 Inhibitors of bacterial nad synthetase |
| 06/27/2001 | EP1109804A1 Chemokine receptor antagonists and methods of use therefor |
| 06/27/2001 | EP1109803A1 Substituted imidazoles having cytokine inhibitory activity |
| 06/27/2001 | EP1109800A1 Novel cdk inhibitors having flavone structure |
| 06/27/2001 | EP1109790A1 1, 2, 4-triazole-3-thione compounds |
| 06/27/2001 | EP1109787A1 Arylpiperazines and their use as metalloproteinase inhibiting agents (mmp) |
| 06/27/2001 | EP1109785A2 Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
| 06/27/2001 | EP1109784A1 Indoline derivatives as 5-ht2b and/or 5-ht2c receptor ligands |
| 06/27/2001 | EP1109619A1 Reactor comprising a contact tube bundle |
| 06/27/2001 | EP1109556A2 New pharmaceutical uses for nos inhibitors |
| 06/27/2001 | EP1109555A1 Novel angiogenesis inhibitors |
| 06/27/2001 | EP1109551A1 4-amino-3-mercapto-1,2,4-triazoles |
| 06/27/2001 | EP1109544A1 Potassium channel inhibitors and method |
| 06/27/2001 | EP1109543A1 Nitrosated and nitrosylated phosphodiesterase inhibitors, compositions and methods of use |
| 06/27/2001 | EP1109542A1 Nitrosated and nitrosylated alpha-adrenergic receptor antagonists, compositions and methods of use |
| 06/27/2001 | EP0950048B1 1-phenylalkyl-1,2,3,6-tetrahydropyridines for treating alzheimer's disease |
| 06/27/2001 | EP0824518B1 (het)aryloxy-, -thio-, aminocrotonates, methods of preparing them and their use as insecticides and fungicides |
| 06/27/2001 | EP0734261B1 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
| 06/27/2001 | CN1301265A Novel substituted arylhydroxamic acids as metalloproteinase inhibitors |
| 06/27/2001 | CN1301263A Pyridyl-pyrazole derivatives, process for their preparation, and their use as herbicides |
| 06/27/2001 | CN1301262A Novel herbicides |
| 06/27/2001 | CN1301255A Heterocyclically substituted amides, their production and their use |
| 06/27/2001 | CN1301253A Carboxy substituted carboxamide derivatives as tachykinin receptor antagonists |
| 06/27/2001 | CN1301161A Serotonergic 5HT receptor compounds for treating ocular and CNS disorders |
| 06/27/2001 | CN1301156A Treatment of T-Helper cell tyre 2 mediated immune diseases with retinoid antagonists |
| 06/27/2001 | CN1301154A Amide derivatives and nociceptin antagonists |
| 06/26/2001 | US6252086 4-alkenyl-and 4-alkynyloxindoles |
| 06/26/2001 | US6252084 Therapy for sepsis shock |
| 06/26/2001 | US6252080 Herpes, cytomegalo virus |
| 06/26/2001 | US6252077 1-(N′-(arylalkylaminoalkyl) aminoisoquinolines; a new class of dopamine receptor subtype specific ligands |
| 06/26/2001 | US6252076 Process for preparation of pyrimidine derivatives |
| 06/26/2001 | US6251949 Oxime derivatives, hydrazone derivatives and use thereof |
| 06/26/2001 | US6251923 Hydroxyindoles, their use as inhibitors of phosphodiesterase 4 and process for their preparation |
| 06/26/2001 | US6251919 Administering aniline derivative for therapy of pain |
| 06/26/2001 | US6251909 Arylglycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 06/26/2001 | US6251907 1-(aryloxyalkyl)-4-(heteroaryl) piperazines and related compounds useful as antipsychotics and analgesics |
| 06/26/2001 | US6251904 Pyrazolopyrimidinone cGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 06/26/2001 | US6251900 Heterocyclic compounds and antitumor agent containing the same as active ingredient |
| 06/26/2001 | US6251894 1-(1,2-disubstituted piperidinyl)-4 (fused imidazole)-piperidine derivatives |
| 06/26/2001 | US6251892 Neurotrophic low molecular weight small molecule n-oxides of heterocyclic esters, amides, thioesters and ketones; inhibitors of enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase or rotamase |
| 06/24/2001 | CA2329516A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 06/21/2001 | WO2001044239A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | WO2001044234A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |
| 06/21/2001 | WO2001044231A1 Improved omeprazole process and compositions thereof |
| 06/21/2001 | WO2001044229A1 Chemokine receptor binding heterocyclic compounds |
| 06/21/2001 | WO2001044227A1 Phenoxypropanolamines, preparation and therapeutic use thereof |
| 06/21/2001 | WO2001044226A1 Serine protease inhibitors |
| 06/21/2001 | WO2001044223A1 Inhibitors of interleukin 5 gene expression |
| 06/21/2001 | WO2001044213A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/21/2001 | WO2001044206A1 Pyrazine based inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044203A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | WO2001044201A1 Substituted imidazole neuropeptide y y5 receptor antagonists |
| 06/21/2001 | WO2001044200A2 Selective neurokinin antagonists |
| 06/21/2001 | WO2001044195A1 Heterocycle derivatives and drugs |
| 06/21/2001 | WO2001044194A2 Propanoic acid derivatives as integrin inhibitors |
| 06/21/2001 | WO2001044193A1 1,3,4-substituted piperidine analogs and uses thereof in treating addictions |
| 06/21/2001 | WO2001044191A1 4-aminopiperidine derivatives and their use as medicine |
| 06/21/2001 | WO2001044179A1 Novel succinate compounds, compositions and methods of use and preparation |
| 06/21/2001 | WO2001044178A1 Novel urea compounds, compositions and methods of use and preparation |
| 06/21/2001 | WO2001044172A1 Salicylamides as serine protease and factor xa inhibitors |
| 06/21/2001 | WO2001043746A1 Medicinal composition |
| 06/21/2001 | WO2001043744A1 Phenoxypropanolamines, method for producing them and pharmaceutical compositions containing them |
| 06/21/2001 | WO2001043743A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 06/21/2001 | WO2001043740A1 Antipsychotic heterocycle compounds |
| 06/21/2001 | WO2001029245A3 ENZYMATIC PROCESS FOR THE RESOLUTION OF ENANTIOMERIC MIXTURES OF β-LACTAMS |
| 06/21/2001 | US20010004669 For treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain and chronic paroxysmal hemicrania and headache associated with vascular disorders |
| 06/21/2001 | CA2395474A1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 06/21/2001 | CA2395088A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | CA2395075A1 1,3,4-substituted piperidine analogs and uses thereof in treating addictions |
| 06/21/2001 | CA2394639A1 Salicylamides as serine protease and factor xa inhibitors |
| 06/21/2001 | CA2394570A1 N-(1-phenylethyl)-5-phenyl-imidazole-2-amine compounds, their compositions and uses |
| 06/21/2001 | CA2394548A1 Antipsychotic heterocycle compounds |
| 06/21/2001 | CA2393825A1 Novel succinate compounds, compositions and methods of use and preparation |
| 06/21/2001 | CA2393672A1 Selective neurokinin antagonists |
| 06/21/2001 | CA2393366A1 Improved omeprazole process and compositions thereof |
| 06/21/2001 | CA2393358A1 Heterocycle derivatives and drugs |
| 06/21/2001 | CA2393027A1 Inhibitors of interleukin 5 gene expression |
| 06/21/2001 | CA2392894A1 New p2x7 receptor antagonists for use in the treatment of inflammatory, immune or cardiovascular diseases |
| 06/20/2001 | EP1109070A2 1,4-Dihydropyridine charge control agents for electrostatographic toners and developers |
| 06/20/2001 | EP1108720A1 Herbicidal 2-Pyrazolyl-6-Aryloxy-Pyri(mi)dines |
| 06/20/2001 | EP1107965A1 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application |
| 06/20/2001 | EP1107964A1 Isoquinoline derivatives with angiogenesis inhibiting activity |
| 06/20/2001 | EP1107963A1 Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 06/20/2001 | EP1107962A1 Quinolin-2-one derivatives useful as anticancer agents |